[Objectives]The paper was to investigate the clinical effects of Zhenwu Decoction combined with Tingli Dazao Xiefei Decoction in the treatment of chronic heart failure with edema syndrome due to yang deficiency.[Metho...[Objectives]The paper was to investigate the clinical effects of Zhenwu Decoction combined with Tingli Dazao Xiefei Decoction in the treatment of chronic heart failure with edema syndrome due to yang deficiency.[Methods]Eighty patients with chronic heart failure were randomly divided into 2 groups(control group and treatment group),with 40 cases in each group.The patients in the control group were treated with conventional western medicine for 14 d,and the patients in the treatment group were treated with Zhenwu Decoction and Tingli Dazhao Xiefeng Decoction on the basis of the control group for 14 d.The curative effect of traditional Chinese medicine(TCM)syndrome score,left ventricular ejection fraction(LVEF),plasma N-terminal brain natruretic peptide precursor(NT-proBNP)and New York Heart Association(NYHA)functional class were compared between the two groups before and after treatment.Minnesota living with heart failure questionnaire in the principle of Chinese civilization and traditional medicine characteristics(C-MLHF)at admission and 1 month after discharge were compared between the two groups.[Results]After treatment,the total effective rate of TCM syndrome score in the treatment group was 82.50%,and that in the control group was 67.50%.The curative effect of TCM syndrome score in the treatment group was better than that in the control group(P<0.05).After treatment the LVEF in both groups was increased compared with that before treatment,and the NT-proBNP level was decreased compared with that before treatment(P<0.05),and those in the treatment group were better than those in the control group.The total effective rate of cardiac function in the treatment group was 87.50%,and that in the control group was 65.00%.The improvement of cardiac function in the treatment group was better than that in the control group(P<0.05).One month after discharge,C-MLHF scores in both groups were decreased compared with those before treatment,and that in the treatment group was lower than in the control group(P<0.05).[Conclusi展开更多
[Objectives]The action mechanism of Tingli Dazao Xiefei Decoction in the treatment of COPD was explored by the network pharmacology and molecular docking technology.[Methods]The TCMSP database was used to perform acti...[Objectives]The action mechanism of Tingli Dazao Xiefei Decoction in the treatment of COPD was explored by the network pharmacology and molecular docking technology.[Methods]The TCMSP database was used to perform active ingredient screening and target prediction on Chinese medicines contained in Tingli Dazao Xiefei Decoction,and COPD-related targets were searched through disease databases.Common targets of Tingli Dazao Xiefei Decoction and COPD were imported into Metascape database for GO analysis and KEGG pathway enrichment analysis.The STRING database was used to perform PPI analysis on common targets,and core targets were screened through the Cytoscape software.The Pymol,AutoDockTools,Vina and other software were used for molecular docking of some core targets and ingredients.[Results]From Tingli Dazao Xiefei Decoction,26 active ingredients which shared 211 common targets and 22 core targets with COPD,were screened out.Enrichment analysis revealed a total of 1892 biological processes,78 cell components,152 molecular functions,and 164 signal paths.The molecular docking of part of the core targets and corresponding ingredients obtained better results.[Conclusions]Tingli Dazao Xiefei Decoction treats COPD through multiple targets and multiple pathways,revealing its mechanism for treating COPD.展开更多
目的评价补阳还五汤合葶苈大枣泻肺汤加减结合西医常规疗法治疗慢性心力衰竭(chronic heart failure,CHF)气虚血瘀饮停证的临床疗效。方法将符合入选标准的2017年11月-2019年11月石景山区中医医院内科CHF患者70例采用随机数字表法分为2...目的评价补阳还五汤合葶苈大枣泻肺汤加减结合西医常规疗法治疗慢性心力衰竭(chronic heart failure,CHF)气虚血瘀饮停证的临床疗效。方法将符合入选标准的2017年11月-2019年11月石景山区中医医院内科CHF患者70例采用随机数字表法分为2组,每组35例。对照组给予CHF西医基础治疗,治疗组在对照组基础上结合补阳还五汤合葶苈大枣泻肺汤加减治疗。2组均治疗2周。分别于治疗前后进行中医证候评分;采用明尼苏达州心功能不全生命质量量表(Minnesota Living with Heart Failure Questionnaire,MLHFQ)评价患者生活质量;采用Lee氏心衰计分法评价症状严重程度;采用ELISA法检测N末端B型利钠肽原(N-terminal pro-B type natriuretic peptide,NT-proBNP),观察治疗期间的不良反应,评价临床疗效。结果治疗组总有效率为91.4%(32/35)、对照组为77.1%(27/35),2组比较差异有统计学意义(χ^(2)=7.050,P=0.014)。治疗后,治疗组血清NT-proBNP[(1725.3±1473.8)ng/L比(2485.7±2164.4)ng/L;U=341.200,P=0.031]水平低于对照组;NT-proBNP下降幅度[(54.3±26.7)%比(35.5±19.8)%;U=4.310,P=0.003]高于对照组。治疗组治疗后中医证候积分及MLHFQ评分均低于对照组(t值分别为3.785、9.925,P值分别为0.031、0.001)。治疗期间,2组均未见明显不良反应。结论在西医规范化治疗基础上结合补阳还五汤合葶苈大枣泻肺汤加减可提高CHF气虚血瘀饮停证患者的临床疗效,降低NT-proBNP水平以促进心肌损伤的修复,改善患者生活质量。展开更多
基金"Outstanding Innovative Talents Support Program"of Heilongjiang University of Chinese Medicine(051267).
文摘[Objectives]The paper was to investigate the clinical effects of Zhenwu Decoction combined with Tingli Dazao Xiefei Decoction in the treatment of chronic heart failure with edema syndrome due to yang deficiency.[Methods]Eighty patients with chronic heart failure were randomly divided into 2 groups(control group and treatment group),with 40 cases in each group.The patients in the control group were treated with conventional western medicine for 14 d,and the patients in the treatment group were treated with Zhenwu Decoction and Tingli Dazhao Xiefeng Decoction on the basis of the control group for 14 d.The curative effect of traditional Chinese medicine(TCM)syndrome score,left ventricular ejection fraction(LVEF),plasma N-terminal brain natruretic peptide precursor(NT-proBNP)and New York Heart Association(NYHA)functional class were compared between the two groups before and after treatment.Minnesota living with heart failure questionnaire in the principle of Chinese civilization and traditional medicine characteristics(C-MLHF)at admission and 1 month after discharge were compared between the two groups.[Results]After treatment,the total effective rate of TCM syndrome score in the treatment group was 82.50%,and that in the control group was 67.50%.The curative effect of TCM syndrome score in the treatment group was better than that in the control group(P<0.05).After treatment the LVEF in both groups was increased compared with that before treatment,and the NT-proBNP level was decreased compared with that before treatment(P<0.05),and those in the treatment group were better than those in the control group.The total effective rate of cardiac function in the treatment group was 87.50%,and that in the control group was 65.00%.The improvement of cardiac function in the treatment group was better than that in the control group(P<0.05).One month after discharge,C-MLHF scores in both groups were decreased compared with those before treatment,and that in the treatment group was lower than in the control group(P<0.05).[Conclusi
文摘[Objectives]The action mechanism of Tingli Dazao Xiefei Decoction in the treatment of COPD was explored by the network pharmacology and molecular docking technology.[Methods]The TCMSP database was used to perform active ingredient screening and target prediction on Chinese medicines contained in Tingli Dazao Xiefei Decoction,and COPD-related targets were searched through disease databases.Common targets of Tingli Dazao Xiefei Decoction and COPD were imported into Metascape database for GO analysis and KEGG pathway enrichment analysis.The STRING database was used to perform PPI analysis on common targets,and core targets were screened through the Cytoscape software.The Pymol,AutoDockTools,Vina and other software were used for molecular docking of some core targets and ingredients.[Results]From Tingli Dazao Xiefei Decoction,26 active ingredients which shared 211 common targets and 22 core targets with COPD,were screened out.Enrichment analysis revealed a total of 1892 biological processes,78 cell components,152 molecular functions,and 164 signal paths.The molecular docking of part of the core targets and corresponding ingredients obtained better results.[Conclusions]Tingli Dazao Xiefei Decoction treats COPD through multiple targets and multiple pathways,revealing its mechanism for treating COPD.
文摘目的评价补阳还五汤合葶苈大枣泻肺汤加减结合西医常规疗法治疗慢性心力衰竭(chronic heart failure,CHF)气虚血瘀饮停证的临床疗效。方法将符合入选标准的2017年11月-2019年11月石景山区中医医院内科CHF患者70例采用随机数字表法分为2组,每组35例。对照组给予CHF西医基础治疗,治疗组在对照组基础上结合补阳还五汤合葶苈大枣泻肺汤加减治疗。2组均治疗2周。分别于治疗前后进行中医证候评分;采用明尼苏达州心功能不全生命质量量表(Minnesota Living with Heart Failure Questionnaire,MLHFQ)评价患者生活质量;采用Lee氏心衰计分法评价症状严重程度;采用ELISA法检测N末端B型利钠肽原(N-terminal pro-B type natriuretic peptide,NT-proBNP),观察治疗期间的不良反应,评价临床疗效。结果治疗组总有效率为91.4%(32/35)、对照组为77.1%(27/35),2组比较差异有统计学意义(χ^(2)=7.050,P=0.014)。治疗后,治疗组血清NT-proBNP[(1725.3±1473.8)ng/L比(2485.7±2164.4)ng/L;U=341.200,P=0.031]水平低于对照组;NT-proBNP下降幅度[(54.3±26.7)%比(35.5±19.8)%;U=4.310,P=0.003]高于对照组。治疗组治疗后中医证候积分及MLHFQ评分均低于对照组(t值分别为3.785、9.925,P值分别为0.031、0.001)。治疗期间,2组均未见明显不良反应。结论在西医规范化治疗基础上结合补阳还五汤合葶苈大枣泻肺汤加减可提高CHF气虚血瘀饮停证患者的临床疗效,降低NT-proBNP水平以促进心肌损伤的修复,改善患者生活质量。
